Gallic Acid Methyl Ester

Gallic Acid Methyl Ester

SCHEMBL5334274

COC(=O)c1cc(O)c(O)c(O)c1.COc1c(O)cc(C(=O)O)c(C)c1OC.O=C(O)c1cc(O)c(O)c(O)c1.O=C(O)c1cc(O)c(O)c(O)c1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.57
KDM4E B2RXH2 3/20 0.57
POLB P06746 2/20 0.57
FUT7 Q11130 2/20 0.57
TDP1 Q9NUW8 2/20 0.57
XDH P47989 2/20 0.57
GAA P10253 1/20 0.57
NFKB1 P19838 1/20 0.57
GFER P55789 1/20 0.57
NFKB2 Q00653 1/20 0.57
RELA Q04206 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
TPMT P51580 5/20 0.50
PTGS2 P35354 1/20 0.49
POLA1 P09884 1/20 0.47
ANTXR2 P58335 1/20 0.47
CA12 O43570 4/20 0.46
CA1 P00915 4/20 0.46
CA2 P00918 4/20 0.46
CA7 P43166 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gallic Acid Methyl Ester SCHEMBL4604139 1.00 LMNA (0.57) LMNAKDM4EPOLBFUT7TDP1
Gallic Acid Methyl Ester SCHEMBL2573657 0.84 LMNA (0.66) LMNAKDM4EPOLBFUT7TDP1
SCHEMBL670626 0.84 TPMT (0.49) KDM4ETDP1TPMTPTGS2MAPT
Gallic Acid Methyl Ester SCHEMBL10713441 0.82 KDM4E (0.84) LMNAKDM4EPOLBFUT7TDP1
SCHEMBL9716404 0.79 TDP1 (0.47) KDM4EPOLBTDP1GFERTPMT
SCHEMBL669967 0.79 CA12 (0.46) LMNAKDM4EPOLBFUT7TDP1
Syringate SCHEMBL30725929 0.77 PKM (0.53) LMNAKDM4EPOLBFUT7TDP1
Methyl Syringate SCHEMBL5152857 0.76 KDM4E (0.51) LMNAKDM4EPOLBL3MBTL1TPMT
SCHEMBL27732334 0.76 KDM4E (0.71) LMNAKDM4EPOLBFUT7TDP1
Gallic Acid Methyl Ester SCHEMBL39513 0.75 KDM4E (1.00) LMNAKDM4EPOLBFUT7TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185038-A1 Regulation of mammalian keratinous tissue using skin care actives THE PROCTER & GAMBLE COMPANY 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185038-A1 Regulation of mammalian keratinous tissue using skin care actives CUTA, KDM7A, KDM2A LMNA 821/4885KDM4E 6/4885POLB 2965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.